Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster Display session

326P - Synergistic interaction between extracellular matrix and epithelial-mesenchymal transition factors drives invasive and metastatic phenotypes in pulmonary neuroendocrine tumors

Date

28 Mar 2025

Session

Poster Display session

Presenters

Tabatha Prieto

Citation

Journal of Thoracic Oncology (2025) 20 (3): S181-S207. 10.1016/S1556-0864(25)00632-X

Authors

T.G. Prieto1, C.M. Baldavira1, C.S. Faria2, A. Ab'Saber1, T. Takagaki3, V. Capelozzi1

Author affiliations

  • 1 University of Sao Paulo - Faculty of Medicine, Sao Paulo/BR
  • 2 University of Sao Paulo, Faculty of Medicine, São Paulo/BR
  • 3 InCor - Instituto do Coracao - HCFMUSP, Sao Paulo/BR

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 326P

Background

Pulmonary neuroendocrine tumors (PNETs) account for about 20% of lung cancer cases and include small cell lung carcinomas (SCLC), large cell neuroendocrine carcinomas (LCNEC), atypical carcinoids, and typical carcinoids (TC). The extracellular matrix (ECM) is essential in regulating cell behavior, but its role in PNETs aggressiveness is not well clarified. Further, the epithelial-mesenchymal transition (EMT) is critical for cancer progression and metastasis, enhancing malignancy through interactions with ECM components.

Methods

We analyzed 38 surgically resected, formalin-fixed, paraffinembedded samples of SCLC (N=33), LCNEC (N=3), and AC (N=2). The expression levels of ECM and EMT-related proteins were detected using immunohistochemistry and quantified with QuPath software.

Results

Our results revealed high expression of COL5A2, COL3A1, ITGB1, and CDH1, whereas CDH2 and ZEB1 showed expression levels below the median in most cases. Notably, ITGA5 expression was negative in 94.7% of patients. No significant correlation was found between markers and clinicopathological features. However, we identified positive correlations between ITGB1 and CDH1 (ρ=0.21; p=0.05), ITGB1 and CDH2 (ρ=0.40; p < 0.01), COL3A1 and COL5A2 (ρ=0.23; p=0.03), and CDH1 and CDH2 (ρ=0.31; p=0.05). Our study revealed high CDH1 expression in 57.9% of patients, compared to just 7.9% for N-cadherin (CDH2), indicating that PNETs, similar to other invasive carcinomas, retain epithelial markers during metastasis. ECM remodeling by COL3A2, COL5A2, and ITGB1 supports CDH1 expression, preserving cohesive tumor cell clusters. A multivariate Cox regression analysis identified age, along with the expression levels of COL3A1, ITGB1, and CDH2, as independent prognostic factors for overall survival (OS), with younger patients and those with high levels of these markers having poorer OS rates.

Conclusions

We hypothesize that the interaction between the ECM and EMT factors is essential for tumor progression in PNETs, and also that cancer cells invade the surrounding stroma in cohesive clusters, connected by CDH1, which enhances invasion and metastasis, affecting patient survival.

Legal entity responsible for the study

The authors.

Funding

Sao Paulo Research Foundation (2018/20403-6, 2023/02755-0, 2023/09682-9; 2023/01158-9), The National Council for Scientific and Technological Development (303735/2021-0; 151118/2023-0).

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.